# FDA recall D-0260-2024

> **Strides Pharma Inc.** · Class II · drug recall initiated 2023-12-29.

## Product

Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16

## Reason for recall

Failed Dissolution Specifications

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0260-2024
- **Recalling firm:** Strides Pharma Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-12-29
- **Report date:** 2024-01-31
- **Termination date:** 2025-07-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0260-2024

## Citation

> AI Analytics. FDA recall D-0260-2024. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-0260-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*